Brief: Almirall Sees 2025 Net Sales Growth Of 10% To 13%
Feb 24 (Reuters) - Almirall SA ALM.MC :
* SEES DOUBLE-DIGIT NET SALES CAGR 2023-2030
* SEES EBITDA MARGIN OF ABOUT 25% BY 2028
* SEES 2025 NET SALES 10% TO 13% GROWTH VERSUS PREVIOUS YEAR
* SEES 2025 TOTAL EBITDA OF BETWEEN €220 MILLION AND €240
MILLION
Source text: https://tinyurl.com/24yczymn
Further company coverage: ALM.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Almirall
See all newsBrief: Almirall Says Phase 3B Adlong Clinical Study Show Treatment Outcomes With Up To Five Years Of Lebrikizumab
Brief: Almirall And CrystalO To Discover, Develop Novel Small Molecules In Medical Dermatology
Almirall shares rise as lower costs beat EBITDA estimates
Brief: Almirall, Certest Biotec Sign Deal to Develop Rare Dermatology Treatments
Spanish stocks - Factors to watch on July 24